Skip to main content
MarketStoryBook

ISRG in “GLP-1 Eats Everything”

Intuitive Surgical, Inc.

Bear sideFadingExposure: not rated yet

Effective pharmacological weight loss could reduce referrals for bariatric surgery, creating a modest headwind for related da Vinci procedures.

ISRG impact map — “GLP-1 Eats Everything”

How this story travels from the headline to ISRG’s own business — positive, negative or mixed, direct or indirect, the mechanism, and how strong the exposure is.

Loading ISRG impact map…

Price history, marked with story events

Oct 20, 2025 – Oct 19, 2026 · 252 sessions

Prices updated during market hours · refreshed about every 30 minutes while the market is open · delayed data, not for trading decisions

Numbered markers tie price moves to earnings, trial or study results, management comments and analyst or demand data. Loading events…

Full story

GLP-1 Eats Everything

Appetite suppression as a macro variable.

BEAR side — Effective pharmacological weight loss could reduce referrals for bariatric surgery, creating a modest headwind for related da Vinci procedures.

Read the full GLP-1 Eats Everything story

Bull side

2 stories
  • Robots Get a Brain

    ISRG in “Robots Get a Brain”

    AcceleratingExposure: not rated yet

    Generative AI is turning machines from rigid equipment into adaptable workers.

    Intuitive Surgical demonstrates how robotics can create durable recurring revenue when precision machines become embedded in professional workflows.

  • Managed Care's Margin Machine Breaks

    ISRG in “Managed Care's Margin Machine Breaks”

    FadingExposure: not rated yet

    Rising utilization, tougher reimbursement and scrutiny of denials are shifting economics from insurers back to care providers.

    Higher procedure volumes increase utilization of Intuitive's installed robotic systems and recurring instrument sales.

Bear side

1 story
  • ISRG in “GLP-1 Eats Everything”

    FadingExposure: not rated yet
    Viewing

    Appetite suppression as a macro variable.

    Effective pharmacological weight loss could reduce referrals for bariatric surgery, creating a modest headwind for related da Vinci procedures.